Quantcast

Latest Telmisartan Stories

everest blood pressure
2014-08-28 03:00:34

Emma Mason, European Society of Cardiology Cardiovascular patients should be cautious when exposed to high altitudes for leisure or work An expedition to Mount Everest by Italian researchers has shown for the first time that blood pressure monitored over a 24-hour period rises progressively as people climb to higher altitudes. The researchers also found that while a drug used for lowering blood pressure, called telmisartan, was effective in counteracting the effects of altitude up to...

2014-03-24 20:23:52

DUBLIN, March 25, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/skgh5l/investigation) has announced the addition of the "Investigation Report on China Telmisartan Market" [http://www.researchandmarkets.com/research/skgh5l/investigation ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) According to statistics from WHO, one-third of the world's adults have high blood pressure. Death toll...

2013-09-25 23:25:11

Reportbuyer.com just published a new market research report: Hypertension Treatment Drugs Markets in China. London (PRWEB) September 25, 2013 China's demand for hypertension treatment drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and...

Men Who Treat Their Diabetes With Insulin Face Higher Risk Of Heart Disease
2012-03-27 07:07:59

Researchers at Brigham and Women´s Hospital (BWH) have conducted a study showing a link between diabetes and heart risks in men. According to the study, men who used insulin to treat their Type 2 diabetes and who did not have a history of cardiovascular disease (CVD) were at a higher risk for major cardiovascular events such as death, heart attack or stroke than those men who had a history of CVD. The BWH team presented their findings at the American College of Cardiology 2012 Annual...

2011-12-09 14:18:24

Different patients may respond differently to each drug Two seemingly similar blood pressure—lowering drugs have different effects on the heart health of dialysis patients, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). The results indicate that certain dialysis patients may benefit more from one drug while some should opt for the other. About 20% of kidney disease patients die within one year after they start dialysis...

2011-06-02 11:21:00

SILVER SPRING, Md., June 2, 2011 /PRNewswire-USNewswire/ --The U.S. Food and Drug Administration today announced that a group of medications used to control high blood pressure, called angiotensin receptor blockers (ARBs), do not increase the risk of developing cancer in patients using the medications. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) In July 2010, the FDA reported that a safety review of ARBs would be performed after a published study found a small increased...

2011-03-21 23:38:47

Elderly patients prescribed combination angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARB) had a higher risk of kidney failure and death, according to a study published in CMAJ (Canadian Medical Association Journal) . This study, by researchers from the University of Alberta and the University of Calgary, sought to determine the safety of combination therapy of ACE inhibitors and ARB in the clinical setting as some randomized trials indicate an increased...

2011-01-24 17:57:09

Canada's health care system could have saved $77 million in 2006 if it had adopted a more restrictive policy on the cardiovascular drugs angiotensin receptor blockers without a negative impact on cardiovascular health, according to a study published in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj100787.pdf. Cardiovascular drug costs in Canada increased by more than 200% from 1996 to 2006. In particular, the use of angiotensin-receptor...

2010-06-13 14:59:00

RIDGEFIELD, Conn., June 13 /PRNewswire/ -- Telmisartan, an angiotensin receptor blocker, is one of the best researched drugs worldwide. It has been studied in clinical trials in more than 50,000 patients. Its positive safety profile has been confirmed also in a market exposure of 34.5 million patient years. Convincing safety data for patients with a high cardiovascular risk were collected in the three long-term outcome trials ONTARGET, PRoFESS and TRANSCEND which followed some of the...


Word of the Day
humgruffin
  • A terrible or repulsive person.
Regarding the etymology of 'humgruffin,' the OED says (rather unhelpfully) that it's a 'made-up word.' We might guess that 'hum' comes from 'humbug' or possibly 'hum' meaning 'a disagreeable smell,' while 'gruffin' could be a combination of 'gruff' and 'griffin.'